Xueqian (Whitney) Liu, Ph.D.
About Xueqian (Whitney) Liu, Ph.D.
Xueqian (Whitney) Liu, Ph.D., is a Principle Scientist at Bristol Myers Squibb with extensive experience in protein/antibody engineering and drug discovery.
Professional Title
Xueqian (Whitney) Liu, Ph.D., currently holds the position of Principal Scientist at Bristol Myers Squibb. Her tenure at the company includes a prior role as a Senior Scientist from 2020 to 2022 in San Diego, California.
Career at Bristol Myers Squibb
Dr. Liu has been with Bristol Myers Squibb as a Principal Scientist, a role she currently occupies. Prior to this, she served as a Senior Scientist at the same organization from 2020 to 2022. Her work at Bristol Myers Squibb is based in San Diego, California, where she has built a significant part of her career.
Previous Roles in Biotechnology
Dr. Liu's extensive experience in biotechnology includes a role as a Scientist in Drug Discovery at Pfenex Inc. for nine months in 2020. Additionally, she has held notable positions at La Jolla Pharmaceutical Company, including Senior Scientist in 2019 for 11 months and Scientist from 2017 to 2018. Her earlier roles include Sr. Scientist and Scientist at Gensun Biopharma, Inc. in Thousand Oaks, California, and a Postdoctoral Research Associate at The Scripps Research Institute from 2012 to 2015.
Educational Background
Dr. Liu's educational background includes a Postdoctoral Research Associate position at The Scripps Research Institute, where she studied Integrative Structural and Computational Biology from 2012 to 2015. She also achieved a Postdoc in Molecular Biology from the University of California, San Diego, between 2009 and 2012. Her earlier academic achievements were completed at Nankai University, where she earned a PhD in Microbiology in 2009 and a BS in Bioscience in 2004.
Technical Skills and Expertise
Dr. Liu possesses a broad range of technical skills, including proficiency in AKTA FPLC systems such as Pure, Avant, and Pilot for protein purification. She is adept in high-throughput gene-to-structure pipelines for cell culture, cloning, protein expression, purification, characterization, and crystallography. Her expertise extends to protein/antibody engineering, molecule design, sequence analysis, and hybridoma cloning. Additionally, she is experienced in managing CRO/CMO relationships, mentoring junior scientists, and using lab management systems like LIMS, ELN, and CBIS.